Jieyu Xing School of Pharmaceutical Sciences Sun Yat-Sen University Biography Publications Institution JoVE Articles Jieyu Xing has not added a biography. If you are Jieyu Xing and would like to personalize this page please email our Author Liaison for assistance. Publications Site-specific PEGylation of an Anti-CEA/CD3 Bispecific Antibody Improves Its Antitumor Efficacy International Journal of Nanomedicine. 2018 | Pubmed ID: 29881272 BiHC, a T-Cell-Engaging Bispecific Recombinant Antibody, Has Potent Cytotoxic Activity Against Her2 Tumor Cells Translational Oncology. Oct, 2017 | Pubmed ID: 28797938 A Single-domain Antibody-linked Fab Bispecific Antibody Her2-S-Fab Has Potent Cytotoxicity Against Her2-expressing Tumor Cells AMB Express. Dec, 2016 | Pubmed ID: 27112931 A Targeted IL-15 Fusion Protein with Potent Anti-tumor Activity Cancer Biology & Therapy. 2015 | Pubmed ID: 26176990 פילוח GPC3 נוגדן Bispecific, GPC3-S-חיובי, עם חזק Cytotoxicity Yanlan Wang1,2, Jiayu Liu1,2, Haitao Pan1,2, Jieyu Xing1,2, Xiaoqiong Wu1,2, Qing Li1,2, Zhong Wang1,2 1School of Pharmaceutical Sciences, Sun Yat-Sen University, 2Center for Cellular & Structural Biology, Sun Yat-Sen University JoVE 57588 Cancer Research
פילוח GPC3 נוגדן Bispecific, GPC3-S-חיובי, עם חזק Cytotoxicity Yanlan Wang1,2, Jiayu Liu1,2, Haitao Pan1,2, Jieyu Xing1,2, Xiaoqiong Wu1,2, Qing Li1,2, Zhong Wang1,2 1School of Pharmaceutical Sciences, Sun Yat-Sen University, 2Center for Cellular & Structural Biology, Sun Yat-Sen University JoVE 57588 Cancer Research
